Private Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$662K Sell
552
-57
-9% -$58.2K 0.02% 231
2026
Q1
$560K Buy
609
+22
+4% +$22.3K 0.02% 228
2025
Q4
$631K Sell
587
-10
-2% -$9.56K 0.02% 216
2025
Q3
$456K Sell
597
-11
-2% -$8.19K 0.01% 221
2025
Q2
$474K Sell
608
-41
-6% -$31.9K 0.02% 208
2025
Q1
$536K Hold
649
0.02% 158
2024
Q4
$501K Hold
649
0.02% 161
2024
Q3
$575K Hold
649
0.02% 156
2024
Q2
$588K Buy
649
+67
+12% +$53.6K 0.02% 154
2024
Q1
$453K Hold
582
0.02% 166
2023
Q4
$339K Hold
582
0.01% 170
2023
Q3
$313K Sell
582
-121
-17% -$62.4K 0.01% 158
2023
Q2
$330K Buy
703
+52
+8% +$21.8K 0.01% 158
2023
Q1
$224K Sell
651
-15
-2% -$5.06K 0.01% 173
2022
Q4
$244K Hold
666
0.01% 166
2022
Q3
$215K Hold
666
0.01% 166
2022
Q2
$216K Buy
+666
New +$200K 0.01% 168

Other funds holding LLY

Private Management Group's LLY Position: Q2 2026 in Review

Private Management Group reduced its Eli Lilly (LLY) stake by 9.4% in Q2 2026, selling an estimated $58.2K and leaving 552 shares worth $662K. The position accounts for 0.02% of the portfolio, ranked #231.

Private Management Group first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Private Management Group held 552 shares of Eli Lilly worth $662K as of Q2 2026.
  • Private Management Group sold 57 Eli Lilly shares in Q2 2026, an estimated $58.2K.
  • Eli Lilly made up 0.02% of Private Management Group's portfolio in Q2 2026, its #231 holding.
  • Private Management Group first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Private Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.